Jing Tu

Jing Tu is the Head of Corporate Planning and Strategy at Alliance Pharma (PA, USA). Jing has been working in the CRO and pharmaceutical industry since 2011. She started her career with Frontage Laboratories (PA, USA) in its biologics ligand binding services lab. As a Frontage scientist, she was then selected by Janssen R&D (formerly Centocor) to work within their ligand-binding laboratories in Spring House (PA, USA). In 2015, Jing joined PPD Laboratories’ (VA, USA) biomarker lab and started its biomarker ligand binding assay group. In 2018, Jing Joined the AbbVie DMPK department Worcester site (MA, USA) and led its preclinical large molecule bioanalysis and immunology biomarker support.

Jing has an MBA degree from Yale University (CT, USA) and graduated as the Class Marshall. She also has a medical degree from Norman Bethune School of Medicine Jilin University (Changchun, China).

Jing was a member of the Global CRO Council (GCC) from 2016 to 2018. She is also a current member of the organizing committee for Applied Pharmaceutical Analysis (APA), Bioanalysis Zone Leader and Expert Columnist. In 2018, she was named the winner of the Bioanalysis Rising Star Award.

What three things would you take if you were stranded on a desert island?

• A solar-powered satellite signal Xbox
• A life-support station
• Friends

If you weren’t a bioanalyst what would you be?

• An astronomer that watches stars every day

What is your favorite city?

• Rome

Why have you decided to become a Young Zone Leader?

It is an excellent platform that will allow me to connect with talented peers in the field, and to share experiences and knowledge.